ArticleThe Lancet regional health. Western Pacific2025
Burden of scabies and bacterial skin infection in Kiribati: results of a national population-based survey 2023.
Article in The Lancet regional health. Western Pacific, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Scabies is a treatable neglected tropical disease with a high burden in Pacific island countries. Scabies is strongly associated with bacterial skin infection, which can lead to long-term sequelae. There is a paucity of epidemiologic data from Kiribati relating to scabies and bacterial skin infection. Methods: We conducted a community-based cross-sectional survey over three weeks in November 2023 to determine the national prevalence of scabies and bacterial skin infection. Participants were recruited from ten evaluation units across all five divisions of Kiribati, including several outer islands from different island groups. All residents of visited households were eligible to participate. Trained nurses conducted clinical assessments, including focused clinical history and skin examination, for scabies and/or bacterial skin infection. Diagnosis of scabies was based on the 2020 International Alliance for the Control of Scabies diagnostic criteria. Assessment of 10,515 participants was completed. We calculated weighted prevalence, risk ratio (RR), and risk difference (RD), with 95% confidence intervals (CI), for scabies and bacterial skin infection, accounting for clustering by household. Findings: The overall weighted prevalence of scabies was 24.9% (95% CI 22.3-27.8). The highest prevalence was observed among infants aged less than 1 year at 47.2% (95% CI 40.8-53.7). Scabies was classified as moderate to severe in 64.9% (95% CI 59.1-70.2) of cases. The overall prevalence of bacterial skin infection was 7.9% (95% CI 6.8-9.2). The population attributable fraction of bacterial skin infection associated with scabies was 79.5% (95% CI 76.4-82.6). Interpretation: Our findings highlight the high burden of scabies and bacterial skin infection in Kiribati and the need for public health action to reduce the impact of both conditions. Funding: The study was funded by the Cameron Foundation (Australia) and the World Scabies Program, Murdoch Children's Research Institute.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.